May 07, 2026
New Oncology Prior Authorization Code Requirement Announced
New Oncology Prior Authorization Code Requirement Announced
Effective October 01, 2026, prior authorization will be required for HCPCS code J2860, Injection, siltuximab, 10 mg, when administered in an outpatient setting for the treatment of a cancer diagnosis.
| HCPCS code | Description |
| J2860 | Injection, siltuximab, 10 mg |
This update is being made to align with procedure code changes from CMS and/or the American Medical Association.
Affected plans
The prior authorization requirement will apply to:
- UnitedHealthcare commercial plans
- UnitedHealthcare Medicare Advantage plans in all states
- UnitedHealthcare Community Plan in select states
- UnitedHealthcare Individual Exchange plans, also known as UnitedHealthcare Individual & Family ACA Marketplace plans, in select states
UnitedHealthcare Community Plan
- Arizona
- Colorado
- Florida
- Hawaii
- Kansas
- Kentucky
- Louisiana
- Maryland
- Mississippi
- Nebraska
- New Jersey
- New Mexico
- New York
- Ohio
- Pennsylvania
- Rhode Island
- Tennessee
- Texas
- Virginia
- Washington
- Wisconsin
UnitedHealthcare Individual Exchange plans
- Alabama
- Arizona
- Colorado
- Louisiana
- Maryland
- Michigan
- Missouri
- Mississippi
- North Carolina
- Nebraska
- Florida
- Georgia
- Indiana
- New Jersey
- New Mexico
- New York
- Ohio
- Oklahoma
- South Carolina
- Tennessee
- Illinois
- Iowa
- Kansas
- Texas
- Virginia
- Washington
- Wisconsin
- Wyoming
Questions and support
Providers with questions can contact UnitedHealthcare oncology support by emailing unitedoncology@uhc.com, visiting the Oncology Prior Authorization and Notification page, or calling oncology prior authorization support at 888-397-8129.
